Matrix metalloproteinase 13 genotype in rs640198 polymorphism is associated with severe coronary artery disease

Disease Markers

Volumn 33, Issue 1, 2012, Pages 43-49

  Vašku, Anna ^a   Meluzín, Jaroslav ^b   Blahák, Jan ^a   Kincl, Vladimír ^b   Goldbergová, Monika Pávková ^a   Sitar, Jan ^b   Zlámal, Filip ^a   Bienertová Vašk, Julie ^a   Vítovec, Jiří ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

CAD; MMP 13; rs640198; severity

Indexed keywords

C REACTIVE PROTEIN; COLLAGENASE 3; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTRON; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 84862865405     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2012/795739     Document Type: Article

References (31)

1. J. Anacker, S.E. Segerer, C. Hagemann, S. Feix, M. Kapp, R. Bausch, U. Kämmerer, Human decidua and invasive trophoblasts are rich sources of nearly all human matrix metalloproteinases. Mol Hum Reprod (12 May 2011). [Epub ahead of print].
2. P. Basu, U. Sen, N. Tyagi, S.C. Tyagi, Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function. Vasc Health Risk Manag 6 (2010), 215-28.
3. J.L. Beaudeux, P. Giral, E. Bruckert, M.J. Foglietti, M.J. Chapman, [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects]. Ann Biol Clin (Paris) 61 (2003), 147-58.
4. C. Cevik, M. Otahbachi, K. Nugent, C. Warangkana, G. Meyerrose, Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on serum matrix metalloproteinase-13 and tissue inhibitor matrix metalloproteinase-1 levels as a sign of plaque stabilization. J Cardiovasc Med (Hagerstown) 9 (2008), 1274-1278.
5. C.P. Chang, K. Stankunas, C. Shang, S.C. Kao, K.Y. Twu, M.L. Cleary, Pbx1 functions in distinct regulatory networks to pattern the great arteries and cardiac outflow tract. Development 135 (2008), 3577-3586.
6. C. Cheng, D. Tempel, R. van Haperen, L. van Damme, M. Algür, R. Krams, R. de Crom, Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype. Atherosclerosis 204 (2009), 26-33.
7. M.P. de Maat, J.W. Jukema, S. Ye, A.H. Zwinderman, P.H. Moghaddam, M. Beekman, J.J. Kastelein, A.J. van Boven, A.V. Bruschke, S.E. Humphries, C. Kluft, A.M. Henney, Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am J Cardiol 83 (1999), 852-856.
8. A. Didangelos, X. Yin, K. Mandal, M. Baumert, M. Jahangiri, M. Mayr, Proteomics characterization of extracellular space components in the human aorta, Mol Cell Proteomics 9 (2010), 2048-2062.
9. S. Fallah, M. Seifi, A. Ghasemi, M. Firoozrai, A. Samadikuchaksaraei, Matrix metalloproteinase-9 and paraoxonase 1 Q/R192 gene polymorphisms and the risk of coronary artery stenosis in Iranian subjects. J Clin Lab Anal 24 (2010), 305-310.
10. A.D. Hingorani, T. Shah, M. Kumari, R. Sofat, L. Smeeth, Translating genomics into improved healthcare, BMJ 341 (2010), c5945. doi: 10.1136/bmj.c5945.
11. R. Kato, Y. Momiyama, R. Ohmori, H. Taniguchi, H. Nakamura, F. Ohsuzu, Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease. Circ J 69 (2005), 1035-1040.
12. C. Irwin, A. Synn, I. Kraiss, O. Zhang, M.M. Griffen, G.C. Hunter, Metalloproteinase expression in venous aneurysms. J Vasc Surg 48 (2008), 1278-1285.
13. V. Knäuper, H. Will, C. López-Otin, B. Smith, S.J. Atkinson, H. Stanton, R.M. Hembry, G. Murphy, Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 271 (1996), 17124-17131.
14. T. Knickelbine, J.R. Lesser, T.S. Haas, E.R. Brandenburg, B.K. Gleason-Han, B. Flygenring, T.F. Longe, R.S. Schwartz, B.J. Maron, Identification of unexpected nonatherosclerotic cardiovascular disease with coronary CT angiography. JACC Cardiovasc Imaging 2 (2009), 1085-1092.
15. C.C. Lin, W.C. Yang, M.Y. Chung, P.C. Lee, Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients. Clin J Am Soc Nephrol 5 (2010), 1805-1814.
16. H.H. Lu, Z.Q. Sheng, Y. Wang, L. Zhang, Levels of soluble adhesion molecules in patients with various clinical presentations of coronary atherosclerosis. Chin Med J (Engl) 123 (2010), 3123-3126.
17. Y. Macotela, M.B. Aguilar, J. Guzmán-Morales, J.C. Rivera, C. Zermeño, F. López-Barrera, G. Nava, C. Lavalle, G. Martínez de la Escalera, C. Clapp, Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin. J Cell Sci 119 (2006), 1790-1800.
18. D. Mao, J.K. Lee, S.J. VanVickle, R.W. Thompson, Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem Biophys Res Commun 261 (1999), 904-910.
19. G.A. McQuibban, J.H. Gong, J.P. Wong, J.L. Wallace, I. Clark-Lewis, C.M. Overall, Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100 (2002), 1160-1167.
20. P.G. Mitchell, H.A. Magna, L.M. Reeves, L.L. Lopresti-Morrow, S.A. Yocum, P.J. Rosner, K.F. Geoghegan, J.E. Hambor, Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97 (1996), 761-768.
21. A.M. Pendás, I. Santamaría, M.V. Alvarez, M. Pritchard, C. López-Otín, Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. Genomics 37 (1996), 266-268.
22. A.M. Pendás, M. Balbín, E. Llano, M.G. Jiménez, C. López-Otín, Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13). Genomics 40 (1997), 222-33.
23. K.D. Rizas, N. Ippagunta, M.D. 3rd Tilson, Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm. Cardiol Rev 17 (2009), 201-210.
24. C. Saracini, P. Bolli, E. Sticchi, G. Pratesi, R. Pulli, F. Sofi, C. Pratesi, G.F. Gensini, R. Abbate, B. Giusti, Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm. J Vasc Surg 55 (2012), 171-179.
25. M. Seifi, S. Fallah, M. Firoozrai, Influence of genetic polymorphism inmatrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis. Arch Med Res 40 (2009), 600-604.
26. K. Stankunas, C. Shang, K.Y. Twu, S.C. Kao, N.A.Y. Jenkins, N.G. Copeland, M. Sanyal, L. Selleri, M.L. Cleary, C.P. Chang, Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease. Circ Res 103 (2008), 702-709.
27. G.K. Sukhova, U. Schönbeck, E. Rabkin, F.J. Schoen, A.R. Poole, R.C. Billinghurst, P. Libby, Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99 (1999), 2503-2509.
28. C. Tarín, M. Gomez, E. Calvo, J.A. López, C. Zaragoza, Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis. Arterioscler Thromb Vasc Biol 29 (2009), 27-32.
29. A. Vasku, M. Goldbergová, L. Izakovicová Hollá, L. Sisková, L. Groch, M. Beránek, S. Tschöplová, V. Znojil, J. Vácha, A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease, Matrix Biol 22 (2004), 585-591.
30. Y. Yu, T. Koike, S. Kitajima, E. Liu, M. Morimoto, M. Shiomi, K. Hatakeyama, Y. Asada, K.Y. Wang, Y. Sasaguri, T. Watanabe, J. Fan, Temporal and quantitative analysis of expression of metalloproteinases (MMPs) and their endogenous inhibitors in atherosclerotic lesions. Histol Histopathol 23 (2008), 1503-1516.
31. B. Zhang, S. Ye, S.M. Herrmann, P. Eriksson, M. de Maat, A. Evans, D. Arveiler, G. Luc, F. Cambien, A. Hamsten, H. Watkins, A.M. Henney, Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99 (1999), 1788-1794.